Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Update on BF&M Transaction

28 Jun 2024 13:00

RNS Number : 3659U
Camellia PLC
28 June 2024
 

28 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Update on BF&M Transaction and change of name of Nominated Adviser

 

Update on BF&M Transaction

 

Further to the most recent update on the disposal of the Company's 36.9% shareholding in BF&M to Argus Group provided in our trading update on 6 June 2024, BF&M Limited ("BF&M") and Argus Group Holdings Limited ("Argus") announced today that the two companies plan to amalgamate (pursuant to Bermuda law), subject to receipt of appropriate shareholder and regulatory approvals (the "Amalgamation"). 

 

This announcement by BF&M and Argus establishes a way forward for regulatory approval of the sale of Camellia's holding of BF&M shares to Argus (the "Sale"). The Amalgamation is expected to take place after the completion of the Sale and special general meetings of BF&M and Argus. As previously announced, we expect the completion of the Sale will take place in the latter part of 2024.

 

To facilitate the timely completion of the Sale and the Amalgamation, Camellia and Argus have agreed that up to $50 million of the agreed $100 million consideration payable to Camellia for the BF&M shares may be deferred in the form of interest-bearing loan notes with a maximum one year term. The Sale is conditional on regulatory approvals and Argus financing. Any loan notes issued will be secured by a pledge over the shares of the buyer and a guarantee from Argus prior to the Amalgamation and, following completion of the Amalgamation, guaranteed by BF&M, the ultimate parent company of the amalgamated entity. If any of the consideration is deferred, Argus will be incentivised to pay down the loan quickly. The Company will provide further updates as appropriate.

 

Change of name of Nominated Advisor

 

The Company announces that its Nominated Adviser and Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, Chief Executive Officer

Oliver Capon, Chief Financial Officer

 

Panmure Liberum 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEANKPAFNLEEA
Date   Source Headline
26th Apr 20071:00 pmRNSFinal Results
18th Apr 20074:44 pmRNSDisposal of investment
18th Apr 20074:39 pmRNSHolding(s) in Company
13th Apr 20073:54 pmRNSKakuzi Limited
20th Dec 20061:56 pmRNSTotal Voting Rights
13th Oct 20063:26 pmRNSTransaction in Own Shares
5th Oct 200610:21 amRNSInterim Report
28th Sep 200612:30 pmRNSInterim Results
27th Sep 200610:09 amRNSAcquisition
11th Aug 20062:29 pmRNSAcquisition
28th Jul 20069:27 amRNSDirectorate Change
12th Jun 200610:52 amRNSResult of AGM
8th Jun 200612:16 pmRNSAGM Statement
7th Jun 200610:31 amRNSAnnual Information Update
8th May 20064:17 pmRNSReport and accounts 2005
27th Apr 20064:05 pmRNSFinal Results
25th Nov 200510:37 amRNSDirectorate Change
18th Nov 20053:21 pmRNSHolding(s) in Company
18th Nov 20052:42 pmRNSDirector/PDMR Sharehldg-Rep
17th Nov 20053:44 pmRNSHolding(s) in Company
17th Nov 20053:43 pmRNSDirector/PDMR Shareholding
17th Nov 20057:01 amRNSAdditional Listing
14th Nov 200512:05 pmRNSStmt re Additional Listing
14th Nov 200512:00 pmRNSResult of Court Hearing
31st Oct 200511:42 amRNSResult of Court Meeting
31st Oct 200511:34 amRNSResult of EGM
30th Sep 200510:40 amRNSEPT Disclosure
29th Sep 20054:43 pmRNSCircular and Interim Report
28th Sep 20057:03 amRNSOffer for Linton Park Plc
28th Sep 20057:02 amRNSOffer for Linton Park Plc
28th Sep 20057:00 amRNSInterim Results
15th Sep 20054:44 pmRNSHolding(s) in Company
15th Sep 20054:34 pmRNSTransfer of Shares
9th Sep 200511:30 amRNSEPT Disclosure
5th Sep 200510:45 amRNSEPT Disclosure
1st Sep 200511:55 amRNSEPT Disclosure
30th Aug 200510:48 amRNSEPT Disclosure
26th Aug 200510:59 amRNSEPT Disclosure
26th Aug 200510:59 amRNSRule 8.3 - Camellia plc
24th Aug 200510:39 amRNSEPT Disclosure
19th Aug 200510:35 amRNSEPT Disclosure
18th Aug 200511:26 amRNSEPT Disclosure
16th Aug 20055:51 pmRNSEPT Disclosure
16th Aug 200510:12 amRNSEPT Disclosure
15th Aug 200510:54 amRNSEPT Disclosure
9th Aug 200510:59 amRNSEPT Disclosure
5th Aug 200510:56 amRNSEPT Disclosure
4th Aug 200510:13 amRNSEPT Disclosure
3rd Aug 200511:51 amRNSRule 8.3- Camellia plc
3rd Aug 200510:17 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.